A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study is a research paper published in The Oncologist (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL148272
NCI NIH HHS
Grant: UG1 CA189819
NCI NIH HHS
Grant: UG1 CA233234
NCI NIH HHS
Grant: U10 CA180868
NCI NIH HHS
Grant: UG1 CA189956
NCI NIH HHS
Grant: UG1 CA233247
NHLBI NIH HHS
Grant: K08 HL146959
NCI NIH HHS
Grant: UG1 CA189828
NCI NIH HHS
Grant: U10 CA180794
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: UG1 CA233270
MeSH Terms
Keywords